Fig. 1From: Standard of care of patients with Chronic Myeloid Leukemia (CML) treated in community based oncology group practices between 2001-2015 in Rhineland-Palatinate (Germany)Best treatment response per patient according to molecular monitoring depending on duration of TKI therapy. TOTAL (N = 210); < 6 months therapy (n = 151); < 12 months therapy (n = 142); ≥ 12 months therapy (n = 175)Back to article page